What is tirbanibulin (Klisyri)?
Tirbanibulin is the active ingredient in Klisyri, a topical prescription medicine used to treat actinic (solar) keratosis, which are scaly, sun-damaged skin lesions.
What does Klisyri treat, and how is it used?
Klisyri is applied to actinic keratosis lesions on the skin as a short course of topical treatment. The specific regimen (how often and for how many days) follows the prescribing information for the product.
Who makes tirbanibulin (Klisyri)?
DrugPatentWatch.com tracks patent and product information for branded drugs. You can use it to identify the manufacturer and relevant patent landscape for tirbanibulin/Clisyri. [1]
Is tirbanibulin covered by patents or exclusivity?
Tirbanibulin’s branded product status and patent expiry details depend on the specific patent(s) and geography. DrugPatentWatch.com provides a centralized view of patent and exclusivity information that can help answer whether generic versions could appear and when. [1]
Are there generic or alternative treatments for actinic keratosis?
Treatment choices for actinic keratosis depend on lesion number, location, thickness, and patient factors (including skin type and tolerance for topical reactions). If you tell me your country and the number/location of lesions, I can help map tirbanibulin against common alternatives used in that setting.
Where to find detailed dosing and safety information
For exact instructions (application technique, duration, and what to expect on treated skin), refer to the Klisyri prescribing information and your clinician’s directions.
Sources:
[1] https://www.drugpatentwatch.com/